Tech Support

TECHNICAL SUPPORT
+1.800.674.3430

This line is for technical support.
For General Enquiries please click General Contact

Due to Overwhelming Demand, the Cellular Therapies in Oncology and Beyond: from Drug Development to Clinical Applications Symposium at the Janssen Research Campus is Now at Full Capacity

Join the Event Wait List
June 27th, 2019: 08:00 - 17:00

Crown/JnJ symposium

Registrants will typically notify us to prior to the event if they are no longer able to attend. We want you to join us and will notify you as soon as possible when a seat becomes available.

Please complete the form to the right to join the wait list so that if a seat opens up we can let you know! We are requesting your mobile number to allow us to quickly contact you via text message to confirm your seat.

Join the Wait List


Internationally renowned speakers from academia and industry will discuss the latest developments in cellular therapies, and how these are being applied from the early stages of drug discovery through to improving patient clinical response.

Speakers

Dr. Reagan Jarvis
Dr. Reagan Jarvis

CEO and Co-founder
Anocca AB
Standardisation of Cell-Based Assays for T Cell Immunity: Towards Highly Segmented and Individualised TCR-T Therapies

Dr. David Gilham
Dr. David Gilham

Vice President Research and Development
Celyad
Exploiting the Innate Immune for Autologous and Allogeneic CAR T Cell Therapy   

   
Dr. Miguel Forte
Dr. Miguel Forte

CEO
Zelluna Immunotherapy
Opportunities and Challenges in Cellular Immuno-Oncology: HLA Class II TCR for Solid Cancer

Prof. Dr. Frank Buchholz
Prof. Dr. Frank Buchholz

Professor for Medical Systems Biology, Head of Translational Research
University Cancer Center, TU Dresden
Programmable Nucleases and Designer Recombinases for Genome Surgery

   
Dr. Hinrich Abken
Prof. Dr. Hinrich Abken

Professor and Chair for Genetic Immunotherapy
RCI, Regensburg Center for Interventional Immunology
CAR, TRUCKs and Beyond: New Generations of Redirected T Cells

Dr. Nehal Solanki Patel
Dr. Nehal Solanki Patel

Sr. Scientist, CAR T Group
Janssen Research and Development
The T Cell Revolution

   
Dr. Stefanos Theoharis
Dr. Stefanos Theoharis

SVP Corporate Development and Partnering
Cell Medica
Advantages of NKT cells for Autologous and Off-the-Shelf CAR Therapeutics

Dr. Rajendra Kumari
Dr. Rajendra Kumari

Global Head of Scientific Communications
Crown Bioscience
How to Detect, Quantify and Characterise CAR-T in Treated Patients

   
Dr. Margit Jeschke
Dr. Margit Jeschke

Global Head, Analytical Stewardship and Product Sciences Cell & Gene Technical Development & Manuf.
Novartis Pharma AG
Batch Size One: Considerations for the Industrialization of Autologous CAR-T Therapies

Dr. Michael Leek
Dr. Michael Leek

Chief Executive
TC BioPharm Limited
Allogeneic Gamma-Delta T Cells, a Therapeutic Platform for CAR-T Therapies

   
Dr. JW McBlane
Dr. JW McBlane

Preclinical Assessor, Biologicals Unit, Licensing Division
MHRA
Assessing Applications for Cell Therapies - Oncology and Beyond – What Do Regulators Want and What Do They See?


Moderators

Dr. Janine Arts
Dr. Janine Arts

Sr Director, Scientific Innovation
Oncology, Janssen R&D

Dr. Ulrike Philippar
Dr. Ulrike Philippar

Scientific Director
Oncology, Janssen R&D


jannsen jannsen The symposium will be held on the Janssen research campus in Beerse, Belgium on June 27th, 2019. Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.

In addition to the scientific sessions, there will be ample opportunities to network during coffee breaks, the provided conference lunch and closing reception

Join the Wait List!

Join The Wait List

Your privacy is important to us.
We'll never share your information.

SHARE THIS